Jubilant Life Scien
ces, an integrated Pharmaceuticals and Life Sciences Company has received Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (US FDA) for Bupropion Hydrochloride Extended-release Tablets USP (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline’s antidepressant Wellbutrin SR. The company has also received approval for Bupropion Hydrochloride Extended-release Tablets USP (SR), 150 mg, the generic version of GlaxoSmithKline’s smoking cessation aid, Zyban.
http://www.epicresearch.co/
0731-664-2300
No comments:
Post a Comment